Heidelberg, Germany

Apogenix Gmbh


USPTO Granted Patents = 11

% Expired Patents = 54.5



Forward Citations = 85

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Oliver Hill (10 out of 35 patents)

silverMedal Christian Gieffers (10 out of 37 patents)

bronzeMedal Meinolf Thiemann (9 out of 38 patents)

4.  Marcus Branschädel (3 out of 5 patents)

5.  Marcus Branschaedel (1 out of 3 patents)

6.  Carmen Fischer (1 out of 1 patent)

7.  Henning Walczak (1 out of 5 patents)

8.  Giorgio Stassi (1 patent)

9.  Matilde Todaro (1 patent)

10.  Christian Giffers (0 patent)

11.  Christian Giefffers (0 patent)


11 patents:

Company Overview
Apogenix GmbH is a biopharmaceutical company based in Heidelberg, Germany, specializing in the development of innovative therapies for cancer and other serious diseases. The company focuses on harnessing the power of its proprietary technology platform to create targeted immunotherapies that modulate the immune system. With a commitment to advancing treatment options, Apogenix aims to improve patient outcomes through its research in the fields of oncology and immunology, contributing to the evolving landscape of biomedicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#40 in Heidelberg

#3,523 in Germany

#51,761 in the World

Heidelberg, DE
Heidelberg, Germany
Forward Citations = 85

7 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Apogenix Gmbh. Retrieved from https://idiyas.com/company/apogenix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…